Preliminary
Vitamin K2 May Slow Aging in Worms by Protecting Mitochondria

This is promising early-stage research showing vitamin K2 can activate aging-control pathways in worms, but we need studies in mammals and eventually humans before knowing if it helps people live …

42 /100
Very recent publication (May 2026) with zero independent replication; C. elegans findings rarely translate to humans; no mention of data …
Preliminary
How light therapy reverses sun damage by changing skin cell signaling

This study explains how intense pulsed light—a popular cosmetic treatment—reverses sun damage at the cellular level by blocking collagen-breakdown pathways. While the mechanism makes sense and early data are encouraging, …

44 /100
No conflict of interest statement visible. Zero citations indicate very recent publication (May 2026) with no replication yet. Human data …
Preliminary
How a Traditional Chinese Herb Might Slow Aging Through Immune and Metabolic Pathways

This is credible mechanistic research showing a traditional herb affects aging pathways in yeast and flies, but it's early-stage: independent replication is needed, and there's no evidence it extends human …

38 /100
Zero citations (very recent publication, awaiting independent replication). Small sample sizes for animal studies (~100 flies per group). Network pharmacology …
Preliminary
Injectable Nicotinamide Riboside Shows Good Safety in Early Human Trials

Injectable nicotinamide riboside appears safe in early testing, but this is only a first small safety check. We need larger studies to know if it actually works or offers real …

27 /100
Preprint (not yet peer-reviewed); very small sample sizes (n=39–45 per trial, 9 groups in Trial 1); Phase 1 designs lack …
Preliminary
Young Blood Plasma Exchange Shows Promise as Safe Treatment for Early Alzheimer's

This study shows that replacing older adults' blood plasma with young donor plasma is safe and can be done in humans—an important first step. But it's far too early to …

27 /100
Preprint (not peer-reviewed); extremely small sample (N=12) with no control group; zero replication or prior studies cited; cannot distinguish treatment …
Preliminary
How naked mole rats rewired their proteins to live exceptionally long

This study reveals a fascinating clue—naked mole rats have evolved unusual protein structures linked to stress resistance—but it's a preliminary computational analysis that needs experimental follow-up to confirm the story …

32 /100
Preprint (unreviewed). Purely computational; no experimental validation. No citations yet (very recent). Predictions about protein phase separation, binding, and degradation …
Preliminary
A Peanut Compound Reverses Blood Stem Cell Aging in Mice

Researchers found a natural compound from peanuts that restored function to aging blood stem cells in mice—an encouraging lead that requires years of additional testing before potential human use. Don't …

42 /100
None identified. Journal is reputable (Aging and Disease, impact factor ~4). Study appropriately cautious in claims. No obvious conflicts of …
Preliminary
AI Reads Your Heart's Age to Predict Heart Disease Risk

This AI tool shows promise for identifying heart disease risk before symptoms appear, but it's preliminary research that needs peer review and validation before doctors would use it clinically. The …

37 /100
Major: Preprint without peer review. Moderate: Modest model performance (r=0.55 age prediction); unclear mechanisms underlying associations; no discussion of clinical …
Preliminary
A Safer Rapamycin-Like Drug Extends Lifespan in Worms

This is early-stage research showing a modified rapamycin might work better than the original drug in simple worms. It's promising but requires years of testing in mammals before anyone should …

36 /100
Study conducted only in C. elegans without parallel safety comparison to parent compound (rapamycin); no pharmacokinetic data provided; zero citations …
Preliminary
Small RNA molecules show promise as aging clocks in blood tests

This editorial makes a reasonable case that scientists should look for better aging biomarkers in blood, but it's a 'think piece' summarizing existing ideas, not proof that these markers work …

33 /100
This is an editorial/commentary, not original research. No new data presented. The cited piRNA work is still emerging and largely …
Preliminary
How Replacing Damaged Cells and Tissues Could Reverse Aging

This is a roadmap from top aging researchers proposing we move beyond slowing aging to actively repairing and replacing damaged cells and tissues. It's a promising vision backed by real …

34 /100
This is a Perspective/Position paper with no original data or human trials—it synthesizes existing literature and expert opinion. No funding …
Preliminary
How Fasting Triggers a Hidden Hormone to Keep Us Healthy as We Age

This study identifies a hormone pathway that explains how fasting improves health during aging in worms—a finding that could eventually inform human therapies, but needs confirmation in mammals before drawing …

43 /100
First report with zero replications; restricted to C. elegans; mammalian translation speculative; limited transparency on sample sizes and statistical methods …
Preliminary
Blood pressure drug losartan rejuvenates aging metabolism in mice and older adults

Losartan, an old blood-pressure drug, shows promise for reversing aging at the molecular level in both animals and early human tests, but we need larger, longer studies measuring real-world health …

47 /100
First report awaiting replication in independent cohorts. Phase 2 human trial limits sample size and generalizability. No full lifespan curves …
Preliminary
How a protein tweak keeps blood-forming stem cells young and extends mouse lifespan

This mouse study shows that tweaking a protein to keep blood-stem cells young also extends lifespan, suggesting stem cell health may be crucial for aging. However, the effect is modest, …

42 /100
Single transgenic line (limited replication within study); modest lifespan extension (~10%, requires confirmation); causal link between HSC function and lifespan …
Preliminary
A New NAD+ Supplement Boosts Cells' Energy Without Raising Blood Levels

This early-stage study shows a clever new way to get NAD+ inside cells efficiently, but it's far too preliminary to claim any anti-aging benefit. We're seeing a biomarker shift in …

34 /100
Preprint (not peer-reviewed); retrospectively registered trial (registered 01/04/2026, after study completion—major bias risk); very short duration (5 days); small sample …
Preliminary
How Your Body's Own Molecules Fight Aging by Neutralizing Toxic Metabolites

This is promising early-stage research suggesting your body has a natural defense against a form of metabolic damage that drives aging, and common dietary supplements may activate it. However, it's …

25 /100
Preprint—no peer review. Zero citations; findings unreplicated. Sample sizes undisclosed. Lifespan extension shown only in artificial transgenic Drosophila model (p300 …
Preliminary
How DNA Chaos in Yeast Chromosomes Drives Aging and Life Span Differences

Researchers found a plausible molecular explanation for why genetically identical cells age at different rates, but the work is very early-stage and needs independent peer review and validation before drawing …

26 /100
Preprint (not peer-reviewed). No citation count (brand new). Sample sizes not clearly stated in abstract. No mention of data availability, …
Preliminary
Poor neighborhoods linked to faster biological aging in DNA

Living in disadvantaged neighborhoods appears linked to faster biological aging at the DNA level, but this preprint needs peer review and larger studies before we can be confident in the …

33 /100
Major: This is an unreviewed preprint (Apr 2026, zero citations)—findings await peer review. Sample limited to healthy young adults (mean …
Preliminary
How Reduced Phosphatidylcholine Affects Aging and Lifespan in Worms

This early-stage study suggests that how cells build their outer membranes may affect aging, but the findings in worms need to be tested in larger animals and humans before we …

30 /100
Preprint status (not peer-reviewed). Lifespan data incompletely reported in abstract. C. elegans model has limited human relevance. No independent replication. …
Preliminary
Aging May Be a Spreading Disorder of System-Wide Coordination

This is an intriguing new way to measure aging by tracking how well your body's systems stay coordinated—early results look promising, but the idea is so new it needs independent …

37 /100
Preprint status (unreviewed). Novel metric (DISCO) with no prior validation or independent replication—zero citations from other groups. Lacks transparency on …